Through metabolomic profiling using a combination of highthroughput liquid and gas chromatographybased mass spectrometry on a total of 69 patientderived glioma specimens, this report documents the discovery. Along with that if my platelets are above 100,000 i will get a once every three weeks infusion of cpt11. Metabolic modulation of glioblastoma with dichloroacetate science translational medicine, 2 31, 31 doi. Metabolic characteristics of gscs were determined by measurement of glucose, oxygen, and glutamine uptake, atp content, and lactate production. May 12, 2010 metabolic modulation may be a viable therapeutic approach in the treatment of glioblastoma. Brain mri showing a large glioblastoma tumour with areas of necrosis within the. Chemical exchange saturation transfer cest is a novel mri contrast mechanism that is. Phase 1 trial of dichloroacetate dca in adults with. We sought to elucidate the role of metformins reported. It has published several case studies about the safety and effectiveness of dca. Metabolic oncology is an exciting new field in cancer research, offering a new window to cancers molecular plasticity and promise for the development of effective, cancerselective therapies and novel biomarkers. Gscs were established from tumors formed by ink4aarfnull, hras v12expressing gliomainitiating cells that differed in extracellular acidification potential. Use of oral dichloroacetate for palliation of leg pain.
However, in the last years, the number of reports supporting dca. A small but mechanistic earlyphase trial of oral dca in patients with gbm showed that the mechanism described in animal models operates in human tumors 18 x 18 michelakis, e. Michelakis ed, sutendra g, dromparis p, webster l, haromy a, niven e, maguire c, gammer tl, mackey jr, fulton d, et al. Glioblastoma gbm is the most common and malignant primary brain tumor.
Altered metabolic enzymes and their metabolites are oncogenic and not simply a product of tumor proliferation. Bonnet et al have reported that treating cancer cells with dichloroacetate dca, an approved treatment for congenital lactic acidosis, reverses the warburg effect and inhibits tumor growth 3,4,68. In conclusion, this study provides the proof of concept that dichloroacetate can effectively sensitize glioblastoma cells to radiotherapy by modulating the metabolic state of tumor cells. Recent reports demonstrate that the antidiabetic drug metformin enhances the damaging oxidative stress associated with dca treatment in cancer cells. Metabolic modulation of glioblastoma with dichloroacetate. We tested whether the smallmolecule and orphan drug dichloroacetate dca can reverse this cancerspecific metabolic and mitochondrial remodeling in glioblastoma. Bonnet et al have reported that treating cancer cells with dichloroacetate. We tested whether the smallmolecule and orphan drug dichloroacetate dca can reverse this. Brain mri showing a large glioblastoma tumour with areas of necrosis within the tumour and significant brain oedema. Metabolic abnormalities in glioblastoma and metabolic strategies to. Dichloroacetate induces apoptosis in endometrial cancer cells. The average survival rate postdiagnosis is only of 14.
Modulation of tumor phi may influence proliferation, apoptosis, chemotherapy resistance, and thermosensitivity. This metabolic remodeling is accompanied by mitochondrial hyperpolarization. Cotreatment with dichloroacetate and omeprazole exhibits a synergistic antiproliferative effect on malignant tumors. Metabolic modulation of clearcell renal cell carcinoma with. Dichloroacetate is an antimetabolite that antagonizes. If youre interested in the study, please read more below. Design we conducted an openlabel study of oral dca in 15 adults with recurrent who grade iii iv gliomas or metastases from a primary cancer outside the central nervous system. It confirmed that dca is an effective anticancer drug for treating glioblastoma patients metabolic modulation of glioblstoma with dichloroacetate, science transltional medicine, vol 2, issue 31. Effects of dichloroacetate as single agent or in combination. Nov 16, 2017 intracellular ph phi plays an important role in the maintenance of normal cell function, and is maintained within a narrow range by the activity of transporters located at the plasma membrane. On of the more promising glioblastoma and malignant astrocytoma treatment options introduces a very old compound called dichloroacetate.
Complex i inhibition augments dichloroacetate cytotoxicity through. All endometriosis drug approvals to date have been contraceptive, limiting their use in women of childbearing age. In addition, a recent study has tested the efficacy of dichloroacetate in a small cohort of patients with glioblastoma, suggesting metabolic modulation through pdk inhibition as a novel therapeutic strategy for the treatment of this devastating brain tumor. The purpose of this study is to evaluate the safety and tolerability of oral dichloroacetate dca in the treatment of recurrent malignant brain tumors rmbts. Therapeutic modulation of cancer metabolism with dichloroacetate. Nobuyuki fukui, kazunari yoshida, hideyuki saya, oltea sampetrean, metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model, neurooncology, volume 20. Metabolic modulation pyruvate dehydrogenase kinase warburg effect dichloroacetate abstract background. Metabolic modulation of glioblastoma with dichloroacetate free download as pdf file. In clinical oncology, dca emerged as a promising safe. Dichloroacetate dca is a synthetic halogenated organic acid which has been used in rare diseases like congenital lactic acidosis. It is an acid, an analogue of acetic acid, in which 2 of the 3 hydrogen atoms of the methyl group have been replaced by chlorine atoms. Cotreatment with dichloroacetate and omeprazole exhibits a.
Through metabolomic profiling using a combination of highthroughput liquid and gas chromatographybased mass spectrometry on a total of 69 patientderived glioma specimens, this report documents the discovery of a parallel. Several publications demonstrated that dca works in a variety of cancers. Aug 02, 2011 9 michelakis ed sutendra g dromparis p webster l haromy a niven e maguire c gammer tl mackey jr fulton d abdulkarim b mcmurtry ms petruk kc metabolic modulation of glioblastoma with dichloroacetate sci transl med 2010 231ra34. Endometriosis is a chronic pain condition affecting. Repurposing dichloroacetate for the treatment of women. Clearcell renal cell carcinoma ccrcc exhibits suppressed mitochondrial function and preferential use of glycolysis even in normoxia, promoting proliferation and suppressing apoptosis. This means it is not a new drug and has been used safely in humans for decades. Medline is the largest medical database in the world, and. The first formal human cancer research using dca was published in may 2010. In addition to the clinical and neuropathology reports, we confirmed gbm identity with fig. Recent studies of human orthotopic gbm in mice and in situ demonstrated gbm cells rely on both glycolysis and mitochondrial oxidation for glucose catabolism. It was originally used in cases of a rare disease called congenital lactic acidosis. Dca dichloroacetate frequently asked questions background. Data were analyzed for each patient from the time they began treatment through.
I am currently taking a low dose of temodar six weeks on and three weeks off 140 m. Background recurrent malignant brain tumors rmbts carry a poor prognosis. Dec 19, 2019 dichloroacetate sodium dca is an inexpensive and simple chemical compound similar to combining vinegar and salt. No controlled clinical trials of dca are available. Metabolic modulation as a novel cancer treatment heart and. Monochloroacetate mca, dichloroacetate dca, and trichloroacetate tca are chlorinated acetates that are formed during water disinfection processes. The relevance of cysteine metabolism in cancer has gained considerable interest in recent years, largely focusing on its role in generating the antioxidant glutathione. The salts and esters of dichloroacetic acid are called. We conducted a randomized control trial, followed by an openlabel study. Like the other chloroacetic acids, it has various practical applications. Hopefully, more and more studies will be directed towards this alternative view of dealing with glioblastoma.
Here we highlight the advantages of why tumor cells, including glioblastoma cells, require metabolic reprogramming and how tumor metabolism can converge on tumor epigenetics and unanswered questions in the field. Targeting tumor metabolism brain tumor brain cancer. Metabolic modulation may be a viable therapeutic approach in the treatment of glioblastoma. It is based on the realization that cancers unique metabolism known since warburgs report in 1923 with suppression of mitochondrial glucose oxidation and upregulation of. Read source document pdf metabolic modulation of glioblastoma with dichloroacetate. Sodium dichloroacetate commonly referred to as dca is a salt of sodium and dichloroacetatic acid. An extensive body of literature describes anticancer property of dichloroacetate dca, but its effective clinical administration in cancer therapy is still limited to clinical trials.
Sensitization of glioblastoma cells to irradiation by modulating the. Metabolic heterogeneity and plasticity of glioma stem cells. To determine whether human gbm could be a target for metabolic therapy with dca, we studied 49 freshly excised consecutive primary gbms 60% male, 48 11 years. The robust glycolytic metabolism of glioblastoma multiforme gbm has proven them. Dichloroacetate induced intracellular acidification in. Introduction glioblastoma multiforme gbm is an aggressive primary brain tumor that exhibits extremely poor responses to approved therapies 1. New for 2019 glioblastoma prognosis treatment with dca. Potential glioblastoma cancer cure with the help of dca. A common fea ture among all gbm and most solid tumor cells is met. Dca increases the flux of pyruvate into the mitochondria by inhibiting the pyruvate dehydrogenase kinase and promotes glucose oxidation over glycolysis. Dichloroacetate dca as a potential metabolictargeting.
Metabolic modulation of clearcell renal cell carcinoma. Pdf solid tumors, including the aggressive primary brain cancer glioblastoma multiforme, develop resistance to cell death, in part as a result of a. Under normal conditions, the material appears in powder form, white color and is soluble in water. Global metabolomic profiling identified an accumulation of several metabolic intermediaries of tryptophan metabolism in glioblastoma.
A number of metabolic pathways that seem to be important for tumor growth are being touted as novel targets for anticancer drug development. The occurrence of side effects such as neurotoxicity as well as the suspicion of dca carcinogenicity still restricts the clinical use of dca. Study of the safety and efficacy of dichloroacetate dca in. Freshly isolated glioblastomas from 49 patients showed mitochondrial hyperpolarization, which was. Complex i inhibition augments dichloroacetate cytotoxicity. Dichloroacetic acid dca, sometimes called bichloroacetic acid bca, is the chemical compound with formula c h cl 2 cooh. Research article cancer metabolic modulation of glioblastoma with dichloroacetate e. Glioblastoma gbm is the most aggressive and common form of primary brain tumour characterized by fast proliferation, high invasion, and resistance to current standard treatment.
The structure of the molecule is similar to a combination of table salt and vinegar. Pdf sensitization of glioblastoma cells to irradiation by. Dca dichloroacetate sodium treatment for cancer cancer. Sensitization of glioblastoma cells to irradiation by modulating the glucose metabolism. Pdf metabolic modulation of glioblastoma with dichloroacetate. Webster l, haromy a, niven e, maguire c, gammer tl, mackey jr, fulton d, et al. Metabolic heterogeneity and plasticity of glioma stem. Sep 11, 2018 metabolic modulation of glioblastoma with dichloroacetate.
Sep 10, 2018 rasm uthmani pdf polisitemia vera finazzi g, barbui t. Modulation of oxidative stress alters dca cytotoxicity towards vmm3 cells. Metabolic modulation of clearcell renal cell carcinoma with dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase. This study also observed that apoptosis was further increased in the glioblastoma stem. It confirmed that dca is an effective anticancer drug for treating glioblastoma patients metabolic modulation of glioblastoma with dichloroacetate, science translational medicine, vol 2, issue 31. Dichloroacetate dca is a synthetic drug which is has been shown to kill cancer cells by taking advantage of cancers particular metabolic process and uses it against it.
This metabolicremodeling isaccompaniedbymitochondrialhyperpolarization. Differential expression of hif1 in glioblastoma multiforme and anaplastic. Inconclusion,thisstudyprovidesthe proof of concept that dichloroacetate can effectively sensitize glioblastoma cells to radiotherapy by modulating the metabolic state of tumor cells. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model. Solid tumors, including the aggressive primary brain cancer glioblastoma multiforme, develop resistance to cell death, in part as a result of a switch from mitochondrial oxidative phosphorylation to cytoplasmic glycolysis. Dichloroacetate dca activates mitochondrial oxidative metabolism and has shown activity against several human cancers. Studies from this application of dca indicate mild to. Dichloroacetate sodium dca is an inexpensive and simple chemical compound similar to combining vinegar and salt.
Kidney cancer metabolic modulation of clearcell renal cell carcinoma with dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase adam kinnairda,b, peter dromparisb, bruno salemeb, vikram gurtub, kristalee watsonc, roxane paulinb, sotirios zervopoulosb, trevor stensonb, gopinath sutendrab, desmond b. The purpose of this research was to report results on longterm administration of dichloroacetate in 36 children with congenital lactic acidosis who participated previously in a controlled trial of this drug. Repurposing dichloroacetate for the treatment of women with. It is defined by the presence of endometriumlike tissue lesions outside the uterus, most commonly on the pelvic peritoneum. Dualtargeting of aberrant glucose metabolism in glioblastoma. Hydroxyurea is the most commonly used cytoreductive agent.
Dca results in daily life from water chlorination and is also a promising drug treatment for treating mitochondrial diseases, pulmonary arterial hypertension and cancer. Further research to determine how well dca works against various cancers within the human body is ongoing. May 12, 2010 solid tumors, including the aggressive primary brain cancer glioblastoma multiforme, develop resistance to cell death, in part as a result of a switch from mitochondrial oxidative phosphorylation to cytoplasmic glycolysis. Sensitization of glioblastoma cells to irradiation by.
Dichloroacetate treatment for mitochondrial cytopathy. Expression of hif1alpha and inos in astrocytic gliomas. Pinkd, katia carminesimmend, ronald moorea, john d lewisd. In contrast to some other tumor types, aberrant glucose metabolism is an important component of gbm growth and chemoresistance. One of the candidates in this class of drugs being investigated is dichloroacetate dca, a molecule used for over 25 years in the treatment of children with inborn errors in mitochondrial function.
Dichloroacetate dca as a potential metabolic targeting therapy for cancer. More recently in the era of targeted therapy, dramatic changes in glucose uptake upon. Metabolic modulation of glioblastoma with dichloroacetate medicor cancer center in canada is a cancer clinic currently offering dca therapy for its patients. Dichloroacetate or dca as it is commonly called as been in use for years to treat a rare genetic disorder called lactic. Jan 14, 2015 metabolic oncology is an exciting new field in cancer research, offering a new window to cancers molecular plasticity and promise for the development of effective, cancerselective therapies and novel biomarkers. The small study proved that dca could be an essential missing part of the gbm treatment. The robust glycolytic metabolism of glioblastoma multiforme gbm has proven them susceptible to increases in oxidative metabolism induced by the pyruvate mimetic dichloroacetate dca. Effects of dichloroacetate as single agent or in combination with gw6471 and metformin in paraganglioma cells.
1479 746 852 1300 420 1040 537 1501 887 94 796 1375 1152 641 134 48 354 873 595 465 1407 79 1495 362 1435 715 680 49 693 887 457 1329 205 1211